Generalized Anxiety Disorder (GAD) in primary health care - Frequencies, recognition and interventions

Psychiatria Danubina

Volumn 10, Issue 4, 1998, Pages 373-376

  Achberger, M ^a   Linden, M ^a  

^a NONE

Author keywords

General health care; Generalized Anxiety Disorder (GAD); Pharmacotherapy; Prevalence; Psychotherapy; Recognition

Indexed keywords

EID: 0000334790     PISSN: 03535053     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (37)

1. Achberger M & Linden M (not yet published): Psychological Distress and Psychiatric Disorders in Primary Health Care Patients in East- and West-Germany one Year after the Fall of the Berlin Wall. Prepared for publication in Social Psychiatry.
2. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders: 4th ed. Washington, DC: American Psychiatric Association, 1994.
3. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders: 3rd ed. Washington, DC: American Psychiatric Association, 1980.
4. Bassler M & Hoffmann SO: Stationäre Psychotherapie bei Angststörungen - ein Vergleich ihrer therapeutischen Wirksamkeit bei Patienten mit generalisierten Angststörung, Agoaphobie und Panikstörung. Psychotherapie, Psychosomatik und medizinische Psychologie, 44, 217-225, 1994.
5. Beek J: Self-help treatment of anxiety disorders. Focus on Depression and Anxiety, 2, 28-36, 1996.
6. Bjerrum H, Allerup P, Thunedborg K, Jakobsen K & Bech P: Treatment of generalized anxiety disorder: comparison of a new beta-blocking drug (CGP 361 A), low-dose neuroleptic (flupenthixol), and placebo. Pharmacopsychiatry, 25(5), 229-132, 1992.
7. Blowers C, Cobb J & Mathews A: Generalized anxiety: a controlled treatment study. Behaviour Research and Therapy, 25, 493-502, 1987.
8. Borkovec TD & Mathews AM: Treatment of non-phobic anxiety disorder: a comparison of non-directive, cognitive and coping desensitisation therapy. Journal of Clinical and Consulting Psychology, 56, 877-884, 1988.
9. Borkovec TD & Costello E: Efficacy of applied relaxation and cognitive-behavioral therapy in the treatment of generalized anxiety disorder. Journal of Consulting and Clinical Psychology, 61, 611-619, 1993.
10. Borkovec TD, Mathews AM, Chambers A, Ebrahimi S, Lytle R & Nelson R: The effects of relaxation training with cognitive or nondirective therapy and the role of relaxation-induced anxiety in the treatment of generalized anxiety. Journal of Consulting and Clinical Psychology, 55, 883-888, 1987.
11. Butler G, Cullington A, Hibbert G, Kilmes I & Gelder M: Anxiety management for persistent anxiety. British Journal of Psychiatry, 151, 535-542, 1987.
12. Butler G, Fernell M, Robson P & Gelder M: Comparison of behavior therapy and cognitive behavior therapy in the treatment of generalized anxiety disorder. Journal of Consulting and Clinical Psychology, 59, 167-175, 1991.
13. Cutler NR, Hesselink JM & Sramek JJ: A phase II multicenter dose-finding, efficacy and safely trial of ipsapirone in outpatients with generalized anxiety disorder. Prog. Neuropsychopharmacol. Biol. Psychiatry, 18(3), 447-463, 1994.
14. Delle-Chiaie R, Pancheri P, Casacchia M, Stratta P, Kotzalidis GD & Zibcllini M: Assessment of the efficacy of buspirone in patients affected by generalized anxiety disorder, shifting to buspirone from prior treatment with lorazepam: a placebo-controlled, double-blind study. J. Clin. Psychopharmacol., 15(1), 12-19, 1995.
15. Dilling H, Mombour W & Schmidt MH: Internationale Klassifikation psychischer Störungen: ICD-10, Kapitel V(F). Klinisch-diagnostische Leitlinien. Huber, Bern, 1991.
16. Faravelli C, Guerini BG & Giardinelli L: Epidemiology of anxiety disorders in Florence. Acta Psychiatrica Scandinavia, 79, 308-312, 1989.
17. Hollifield M, Katon W & Morojele N: Anxiety and depression in an outpatient clinic in Lesotho, Africa. Int J Psychiatry Med, 24(2), 179-188, 1994.
18. Laux L & Gunreben G: Schwere Spätdystonie unter Fluspirilen. Deutsche Medizinische Wochenschrift, 116, 977-980, 1991.
19. Laux L & König W: Langzeileinnahme und Abhängigkeit von Benzodiazepinen - Ergebnisse einer epidemiologischen Studie. In: Hippius H, Engel RR, Laakmann G. (Hrsg.). Benzodiazepine - Rückblick und Ausblick (S. 226-233). Berlin: Springer, 1986.
20. Lecrubier Y, Puech AJ, Azcona A, Bailey PE & Lataste X: A randomized double-blind placebo-controlled study of topisetron in the treatment of outpatient with generalized anxiety disorder. Psychopharmacology, 112, 129-133, 1993.
21. Linden M, Maier W, Achberger M, Herr R, Helmchen H & Benkert O: Psychische Erkrankungen und ihre Behandlung in Allgemeinarztpraxen in Deutschland. Nervenarzt, 67, 205-215, 1996.
22. Lydiard RB, Brawman-Mintzer O & Ballenger JC: Recent developments in the psychopharmacology of anxiety disorders. J Consult Clin Psychol. 64(4), 660-668, 1996.
23. Mancuse DM, Townsend MH & Mercante DE: Longterm follow-up of generalized anxiety disorder. Compr. Psychiatry, 34, 441-446, 1993.
24. Marks J, Goldberg D & Hiller V: Determinants of the ability off general practitioners to detect psychological illness. Psychol. Med. 9, 337-353, 1979.
25. Mathews AM & Gelder MG: Psycho-physiological investigations of brief relaxation training. Journal of Psychosomatic Research, 13, 1-12, 1969.
26. Power KG, Simpson RJ, Swanson V & Wallace LA: Controlled comparison of pharmacological and psychological treatment of generalized anxiety disorder in primary care. British Journal of General Practice, 40, 289-294, 1990.
27. Reich J, Perry JC, Shera D, Dyck I, Vasile R, Goisman RM, Rodriguez-Villa F, Massion AO & Keller M: Comparison of personality disorders in different anxiety disorder diagnoses: panic, agoraphobia, generalized anxiety, and social phobia. Ann Clin Psychiatry, 6(2), 125-134, 1994.
28. Rice KM & Blanchard EB: Biofeedback in the treatment of anxiety disorders. Clinical Psychology Review, 2, 557-577, 1982.
29. Rice KM, Blanchard EB & Purcell M: Biofeedback treatments of generalized anxiety disorder: Preliminary results. Biofeedback Self Regulation, 18, 93-105, 1993.
30. Rickels K, Downing R, Schweizer E & Hassmann H: Antidepressants for the treatment of generalized anxiety disorder. A placebo-controlled comparison of imipramine, trazolone and diazepam. Arch Gen Psychiatry, 50, 844-895, 1993.
31. Rouillon F, Thalassinos M, Ferreri M, Parquet P & Samuelian JC: Etude clinique et epidemiologique du trouble "anxiete generalisee" en medecine generale. Encephale, 20(2), 103-110, 1994.
32. Sherbourne CD, Jackson CA, Meredith LS, Camp P & Wells KB: Prevalence of comorbid anxiety disorders in primary care outpatients. Arch Fam Med, 5(1), 27-35, 1996.
33. Uhlenhuth EH, Balter MB, Ban TA & Yang K: International study of expert judgement on therapeutic use of benzodiazepines and other psychotherapeutic medications: II. Pharmacotherapy of anxiety disorders. J Affect Disord, 18,35(4), 153-162, 1995.
34. Wacker HR, Mullejans R, Klein KH & Battegay R: Identification of cases of anxiety disorders and affective disorders in the community according to ICD-10 and DSM-HII-R by using the composite international interview (CIDI). International Journal of Methods in Psychiatry, 2, 91-100, 1992.
35. Wilcox CS, Ryan PJ, Morrissey JL, Cohn JB, DeFrancisco DF, Linden RD & Heiser JF: A fixed-dose study of adinazolam-SR tablets in generalized anxiety disorder. Prog. Neuropsychopharmacol. Biol. Psychiatry, 18 (6). 979-993, 1994.
36. Wittchen HU, Zhao S, Kessler RC & Eaton WW: DSM-III-R generalized anxiety disorder in the national comorbidity survey. Archives of General Psychiatry, 51, 355-364, 1994.
37. Wurthmann C, Klieser E & Lehmann E: Psychopharmakologische Differentialtherapie generalisierter Angststorungen-Ergebnisse einer Studie mit 30 Einzelfallexperimenten. Fortschr Neurol Psychiatr, 63(8), 303-309, 1995.